These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 6802902)
61. Effect of bacterial lipopolysaccharide on the in vitro secondary antibody response in mice. II. Abrogation of the suppressive capacity of endotoxin. Walker SM; Weigle WO Cell Immunol; 1982 Feb; 67(1):168-72. PubMed ID: 6176336 [No Abstract] [Full Text] [Related]
62. New immunosuppressive activity of dykellic acid. Han SB; Lee HJ; Kho YH; Jeon YJ; Lee SH; Kim HC; Kim HM J Antibiot (Tokyo); 2001 Oct; 54(10):840-3. PubMed ID: 11776441 [No Abstract] [Full Text] [Related]
63. Comparative studies on adjuvanticity of Klebsiella O3 lipopolysaccharide and its lipid A and polysaccharide fractions. Kato N; Kido N; Ohta M; Naito S Immunology; 1985 Feb; 54(2):317-24. PubMed ID: 3881339 [TBL] [Abstract][Full Text] [Related]
64. Inhibition of lipopolysaccharide mitogenicity with characterized anti-lipid A monoclonal antibodies. Girard R; Chaby R Immunology; 1985 Nov; 56(3):481-7. PubMed ID: 2867028 [TBL] [Abstract][Full Text] [Related]
65. [The mechanism on development of autoimmune response by endotoxin]. Yokochi T Nihon Saikingaku Zasshi; 1994 May; 49(3-4):465-73. PubMed ID: 8078184 [No Abstract] [Full Text] [Related]
66. Mhc restriction and Ir genes. Klein J; Nagy ZA Adv Cancer Res; 1982; 37():233-317. PubMed ID: 6222631 [No Abstract] [Full Text] [Related]
67. Macrophage-lymphocyte interactions in immune induction. Feldmann M; Rosenthal A; Erb P Int Rev Cytol; 1979; 60():149-78. PubMed ID: 115808 [No Abstract] [Full Text] [Related]
68. T cell requirements for the expression of the lipopolysaccharide adjuvant effect in vivo: evidence for a T cell-dependent and a T cell-independent mode of action. Ness DB; Smith S; Talcott JA; Grumet FC Eur J Immunol; 1976 Sep; 6(9):650-4. PubMed ID: 1087242 [TBL] [Abstract][Full Text] [Related]
69. Effect of bacterial lipopolysaccharide on the in vitro secondary antibody response in mice. I. Description of the suppressive capacity of lipopolysaccharide. Walker SM; Weigle WO Cell Immunol; 1978 Mar; 36(1):170-9. PubMed ID: 305290 [No Abstract] [Full Text] [Related]
70. Bacterial protein-LPS complexes and immunomodulation. Nixdorff K; Weber G; Kaniecki K; Ruiner W; Schell S Adv Exp Med Biol; 1992; 319():49-61. PubMed ID: 1414605 [No Abstract] [Full Text] [Related]
71. Adjuvant action of capsular polysaccharide of Klebsiella pneumoniae on antibody response. VI. Site of its action. Nakashima I; Nagase F; Kato N Z Immunitatsforsch Immunobiol; 1977 Sep; 153(3):204-16. PubMed ID: 337706 [No Abstract] [Full Text] [Related]
73. Self-recognition as a means of cell communication in the immune system. Katz DH Symp Soc Exp Biol; 1978; 32():411-27. PubMed ID: 112703 [No Abstract] [Full Text] [Related]
74. Clonal selection and the ontogeny of the immune response. D'Eustachio P; Rutishauser US; Edelman GM Int Rev Cytol Suppl; 1977; (5):1-60. PubMed ID: 413803 [No Abstract] [Full Text] [Related]
75. Mode of action of adjuvants: retinol and other lysosome-labilizing agents as adjuvants. Spitznagel JK; Allison AC J Immunol; 1970 Jan; 104(1):119-27. PubMed ID: 4903997 [No Abstract] [Full Text] [Related]
76. Formation of antibody in the newborn mouse: study of T-cell-independent antibody response. Mosier DE; Zaldivar NM; Goldings E; Mond J; Scher I; Paul WE J Infect Dis; 1977 Aug; 136 Suppl():S14-9. PubMed ID: 408430 [TBL] [Abstract][Full Text] [Related]
77. T-cell regulation of restricted B-cell responses. Campos-Neto A; Levine H; Schlossman SF Adv Exp Med Biol; 1978; 98():403-17. PubMed ID: 102127 [No Abstract] [Full Text] [Related]
78. The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells. Thompson BS; Chilton PM; Ward JR; Evans JT; Mitchell TC J Leukoc Biol; 2005 Dec; 78(6):1273-80. PubMed ID: 16204643 [TBL] [Abstract][Full Text] [Related]
79. Induction of splenic T cell proliferation by lipid A in mice immunized with sheep red blood cells. Mita A; Ohta H; Mita T J Immunol; 1982 Apr; 128(4):1709-11. PubMed ID: 7037954 [TBL] [Abstract][Full Text] [Related]
80. New synthetic analogs of lipid A as lipopolysaccharide agonists or antagonists of B lymphocyte activation. Pedron T; Girard R; Eustache J; Bulusu AR; Macher I; Radzyner-Vyplel H; Stütz PL; Chaby R Int Immunol; 1992 Apr; 4(4):533-40. PubMed ID: 1591221 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]